Viewing Study NCT01501266


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-28 @ 4:44 PM
Study NCT ID: NCT01501266
Status: COMPLETED
Last Update Posted: 2016-05-10
First Post: 2011-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Faslodex Specific Clinical Experience Investigation
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-02
Start Date Type: None
Primary Completion Date: 2015-01
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01
Completion Date Type: ACTUAL
First Submit Date: 2011-12-27
First Submit QC Date: None
Study First Post Date: 2011-12-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-05-09
Last Update Post Date: 2016-05-10
Last Update Post Date Type: ESTIMATED